Robust biomanufacturing of insulin-producing cells in controlled and automated bioreactors for Type 1 diabetes treatment

Authors

• Jessica Jiyu Tian, McGill University, CanadaFollow
• Hamid Orimi, Department of Chemical Engineering, McGill University, Canada
• Robert Voyer, Human Health Therapeutics Research Centre, National Research Council Canada, Canada
• Phuong Lan Pham, Human Health Therapeutics Research Centre, National Research Council Canada, Canada
• Nancy MacDonald, Human Health Therapeutics Research Centre, National Research Council Canada, Canada
• Brenden N. Moeun, Department of Chemical Engineering, McGill University, Canada Corinne A. Hoesli, Department of Chemical Engineering, McGill University, Canada
• Corinne A. Hoesli, Department of Chemical Engineering, McGill University, Canada Corinne A. Hoesli, Department of Chemical Engineering, McGill University, Canada

Conference Dates

February 1 – 5, 2026

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Jessica Jiyu Tian, Hamid Orimi, Robert Voyer, Phuong Lan Pham, Nancy MacDonald, Brenden N. Moeun, and Corinne A. Hoesli, "Robust biomanufacturing of insulin-producing cells in controlled and automated bioreactors for Type 1 diabetes treatment" in "Advancing Manufacture of Cell and Gene Therapies IX [2026]", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/79